In the M0 stage, the sensitivity of AFP, CEA, CA125, CA199, and CA242 to detect gastric cancer was 9.95%, 16.92%, 5.47%, 14.43%, 14.93%, respectively, and the sensitivity of combined detection was 35.82%. This evidence concerns the gene CEACAM5 and gastric cancer.